It was reported that high PD-L1 expression in pancreatic cancer tissues with high levels of CD44+/CD133+ CSCs predicts an unfavorable prognosis of pancreatic cancer 11. This evidence concerns the gene PROM1 and familial pancreatic carcinoma.